#LegendNews: Today, we released our 2024 second-quarter financial results, and Jessie Yeung, Vice President of Investor Relations & Finance, shares her thoughts. Read the full report: https://lnkd.in/eyJQSSnu #CellTherapy
About us
Legend Biotech is a global, commercial-stage biotechnology company developing and manufacturing novel therapies. We explore and apply innovative technologies to deliver cutting-edge options for patients around the world. Our corporate headquarters is located in Somerset, NJ, and our manufacturing footprint includes facilities in the United States, China and the Belgium.
- Website
-
https://legendbiotech.com/
External link for Legend Biotech
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Somerset, New Jersey
- Type
- Public Company
- Specialties
- R&D, Cell Therapy, CAR-T, CAR-T Manufacturing, Biotechnology, and Pharmaceuticals
Locations
Employees at Legend Biotech
-
Steve Gavel
Senior Vice President, Cell Therapy Commercial Development
-
Frederik Buysse
-
Kathy Rosseel
HR Director - International HR Manager - Senior Human Resources Business Partner
-
Senthil Arumugam, MBA
Director of IT - Global Business Technology Solutions | Head of Application Development | Cloud Analytics Architect | BI | Data Integration | CRM |…
Updates
-
#LegendNews: We are honored to welcome Peter Salovey, Ph.D., to our Board of Directors. Dr. Salovey brings a wealth of experience that will be invaluable as we strengthen and drive further growth for the company. Read more about his appointment: https://lnkd.in/evRGU_Bc
-
-
Today, our US Head of Human Resources, Selene (Wangshu) Li, will host a speed learning session during the Pre-Conference Focus Day at the LEAP HR Life Sciences East Conference. In the session, she will share her expertise and lead an open discussion on cultivating a strong #CompanyCulture. #WeAreLegend #LEAPHR
-
-
On #WorldLungCancerDay, we reaffirm our dedication to advancing CAR-T #CellTherapy research for those battling small cell lung cancer (#SCLC). Learn more about the cutting-edge CAR-T cell research our scientists are conducting to address this unmet need: https://lnkd.in/g5qhSpYW
-
In honor of #NationalInternDay, we want to recognize the 30 university students who joined us this summer. Over the last several weeks, they have immersed themselves in every aspect of our business by participating in weekly Lunch and Learn sessions featuring different departments. Check out photos from our HR session, where they completed mock interviews and got to walk away with some practical knowledge and tips. #WeAreLegend #Internship
-
-
At Legend Biotech, #CellTherapy research is the foundation of our work. Watch for insights from Wang (Kenneth) Zhang, Executive Director of Research Platform, as he discusses unanswered questions in the cell therapy field and how they will shape the future of research. #WeAreLegend
-
As a token of appreciation to our LEGENDary team, we had a visit from an ice cream truck at our global headquarters in Somerset, NJ. It was the perfect way to cool down and catch up with colleagues on this hot summer day. #WeAreLegend
-
-
#LegendNews: Legend Biotech will host a webcast to share 2024 second-quarter financial results on August 9. Register to join the live webcast here: https://lnkd.in/g8gFDUqv #CellTherapy
-
-
Our LEGENDs in Ghent, Belgium, embody the phrase “one Legend” and often observe special occasions as a team. Recently, they celebrated the summer solstice together. Team building is a favorite pastime at Legend. Would you like to join our growing team? Click here to see our current openings. https://lnkd.in/e-rXFgQq #WeAreLegend
-
-
#LegendNews: As we continue our pursuit to transform patients’ lives, we are pleased to announce a positive interim analysis from our Phase 3 #MultipleMyeloma study. Read the topline results: https://bit.ly/4cNaxHt #CellTherapy
-
Similar pages
Browse jobs
Stock
LEGN
NASDAQ
20 minutes delay
$55.90
-1.01 (-1.775%)
- Open
- 58.9
- Low
- 55
- High
- 58.9
Data from Refinitiv
See more info on